Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:760 (14 April), doi:10.1136/bmj.39177.580729.BE
Other viruses pose greater public health threats, so isn't it time to move on?
| The first 150 words of the full text of this article appear below. |
Emotions still run high over the stocks of smallpox virus placed into the P4 freezers of Atlanta and Novosibirsk more than 30 years ago by the World Health Organization. In this week's BMJ, two articles present opposing views on whether the United States and Russia should destroy their stocks of smallpox virus (Variola).1 2
One argument for maintaining smallpox stocks is that they are needed to develop safer vaccines.1 Our current effective vaccine is safe when used judiciouslynot for mass vaccination of populations, but for targeting those at risk after screening out people with a history of HIV, leukaemia, or eczema at higher risk of complications after vaccination.3 Moreover, new vaccines are based on Vaccinia, not smallpox.4 No new vaccine can be tested for efficacy until human cases of smallpox reappear.
Another argument is that smallpox stocks are needed to assess antiviral agents for the treatment of
Thomas Mack, professor of preventive medicine
Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA
mack@ccnt.usc.edu
Read all Rapid Responses